SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-023254
Filing Date
2021-03-26
Accepted
2021-03-26 17:14:47
Documents
2
Period of Report
2021-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 POA DOCUMENT poa.txt EX-24.3_975711 3080
  Complete submission text file 0001209191-21-023254.txt   6113
Mailing Address C/O THRESHOLD PHARMACEUTICALS, INC. 1300 SEAPORT BOULEVARD, 5TH FLOOR REDWOOD CITY CA 94063
Business Address
Colowick Alan (Reporting) CIK: 0001316163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 21778498

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)